Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA‐1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Medical Virology

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jmv.24889PMID 28661055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular mimicry, genetic homology, and gene sharing proteomic “molecular fingerprints” using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease

  2018cited by this paper
• Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.

  2016cited by this paper
• Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system.

  2016cited by this paper
• Evaluation of the Architect Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgG, VCA IgM, and EBV Nuclear Antigen 1 IgG Chemiluminescent Immunoassays for Detection of EBV Antibodies and Categorization of EBV Infection Status Using Immunofluorescence Assays as the Reference Method

  2014cited by this paper
• Umbilical cord blood transplantation: the first 25 years and beyond.

  2013cited by this paper
• Risk Evaluation and Mitigation Strategies: A Focus on Belatacept

  2013cited by this paper
• Risk of posttransplant lymphoproliferative disorder associated with use of belatacept.

  2013cited by this paper
• Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

  2012cited by this paper
• Prevalence of Epstein-Barr Virus Reactivation in Pregnancy

  2010influential reference
• Lymphoproliferative Disorders and De Novo Malignancies in Intestinal and Multivisceral Recipients: Improved Outcomes With New Outlooks

  2009cited by this paper
• Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

  2009cited by this paper
• Epstein‐Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

  2009cited by this paper
• Epstein–Barr virus infection during pregnancy and the risk of adverse pregnancy outcome

  2005cited by this paper
• Infectious mononucleosis and Epstein-Barr virus

  2004cited by this paper
• Epstein-Barr Virus and Cancer

  2004cited by this paper
• Measurement of EBV‐IgG anti‐VCA avidity aids the early and reliable diagnosis of primary EBV infection

  2003cited by this paper
• Epstein–Barr Virus and Cancer

  2001cited by this paper
• Cross-Reactivity of Epstein-Barr Virus-Specific Immunoglobulin M Antibodies with Cytomegalovirus Antigens Containing Glycine Homopolymers

  2001cited by this paper
• Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus.

  1996cited by this paper
• Spontaneous retropharyngeal haematoma attributable to Epstein-Barr virus infection

  1996cited by this paper
• Evaluation of five enzyme immunoassays for detection of immunoglobulin M antibodies to Epstein-Barr virus viral capsid antigens

  1993cited by this paper
• Assessment of rapid ELISA test for detection of Epstein-Barr virus infection.

  1990cited by this paper
• Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus

  1987cited by this paper
• Detection of active Epstein-Barr infection in pregnant women

  1985cited by this paper
• Infectious mononucleosis and the Epstein-Barr virus.

  1978cited by this paper
• The umbilical cord.

  1960cited by this paper

• Epstein-Barr Virus Infection Related to Low White Blood Cell Count in Cancer Patients Receiving Chemotherapy in Al-Najaf Governorate/Iraq

  2025cites this paper
• Epstein–Barr Virus Infection Related to Low White Blood Cell Count in Cancer Patients Receiving Chemotherapy in Al-Najaf Governorate/Iraq

  2020cites this paper
• Fever in a lung transplant recipient

  2020cites this paper
• Jak zamawiać publikacje MP

  2019cites this paper
• Proteomic “Molecular Fingerprints” Using an Epstein Barr Virus-Derived Microarray as a Diagnostic Method in Autoimmune Disease

  2019cites this paper
• [Immuno-PCR Assay for Quantitation of Antibodies to Epstein-Barr Virus].

  2018cites this paper
• Immuno-PCR Assay for Quantitation of Antibodies to Epstein–Barr Virus

  2018cites this paper
• Molecular mimicry, genetic homology, and gene sharing proteomic “molecular fingerprints” using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease

  2018cites this paper
• Immuno-PCR Assay for Quantitation of Antibodies to Epstein – Barr Virus 1

  2018influential citation